ecancer

Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery

Prof John Neoptolemos - University of Liverpool, Liverpool, UK

5 Jun 2016

METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

5 Jun 2016

Advanced hepatocellular carcinoma and personalised therapy

Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA

4 Jun 2016

Latest in hepatocellular carcinoma treatments

Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA

4 Jun 2016

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK

3 Jun 2016

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA

4 May 2016

Understanding personalised medicine - the e-learning course

Prof Gordon McVie

4 May 2016

p62: Metabolism and the tumour microenvironment

Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA

29 Apr 2016

Editor's Choice for April 2016

Prof Gordon McVie - ecancer Editor

29 Apr 2016

Targeting AFP in hepatocellular cancer

Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA

5 Apr 2016

Patient perspective on immunotherapy and the ITOC-3 conference

Peter Trayhurn - Patient advocate

4 Apr 2016

Editor's Choice for February 2016

Prof Gordon McVie - ecancer Editor

25 Feb 2016

More from ecancer